跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PALAVO Suspension 250mg/5ml - NPRA Drug Approval Details
Approvals
/
NPRA
/
PALAVO Suspension 250mg/5ml
Approved
STANDARD
PALAVO Suspension 250mg/5ml
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Aug 6, 2026
Approval ID
076f2e8de4de05e1
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Type
Standard
Approval Details
Approval Id
076f2e8de4de05e1
Drug Approval Npra Name
PALAVO Suspension 250mg/5ml
Product Name
PALAVO Suspension 250mg/5ml
Registration Number
MAL26076016XZ
Holder Company Name
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Holder Address
1-5, CHENG INDUSTRIAL ESTATE 75250 MALAYSIA
Holder Phone
06-3351515
Manufacturer Company Name
XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD.
Manufacturer Address
1-5 CHENG INDUSTRIAL ESTATE 75250 MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL26076016XZ
Version
1786043434
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Aug 6, 2026
Approval ID
076f2e8de4de05e1
Type
Standard
Source
Official Source
Back to NPRA Approvals